Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Approval Via "Living License" Gaining Backers, But Major Players Not Among Them

Executive Summary

Support appears to be growing for FDA to adjust its approval system, including moving away from what has been called an “all-or-nothing” process to include a limited-launch approval mechanism.

You may also be interested in...



Industry Skeptical Of User Fee Success, PricewaterhouseCoopers Finds

FDA may be wondering whether a lack of praise for its user fee program actually could be a criticism after a survey did not find overwhelmingly agreement the dollars were serving their intended purpose.

Industry Skeptical Of User Fee Success, PricewaterhouseCoopers Finds

FDA may be wondering whether a lack of praise for its user fee program actually could be a criticism after a survey did not find overwhelmingly agreement the dollars were serving their intended purpose.

PDUFA Talks: Four-Phase Review Flops; Automatic Extensions Back On Table

FDA and industry have moved to a more pointed debate of automatic review deadline extensions after the agency decided to drop its four-phase review process proposal.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS052899

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel